These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2854633)
1. The effects of phthalimide and saccharin derivatives on low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptor activity and related enzyme activities. Hall IH; Wong OT; Wyrick SD Pharm Res; 1988 Jul; 5(7):413-20. PubMed ID: 2854633 [TBL] [Abstract][Full Text] [Related]
2. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro. Hall IH; Wong OT; Simlot R; Izydore RA Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628 [TBL] [Abstract][Full Text] [Related]
3. The effects of cyclic imides on lipoprotein receptor binding and degradation of rat and human cells and effects on regulatory enzymes of lipid metabolism. Wong OT; Williams WL; Oswald BS; Hall IH Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):3-32. PubMed ID: 1325661 [TBL] [Abstract][Full Text] [Related]
4. The effects of boron hypolipidemic agents on LDL and HDL receptor binding and related enzyme activities of rat hepatocytes, aorta cells and human fibroblasts. Hall IH; Spielvogel BF; Griffin TS; Docks EL; Brotherton RJ Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):297-317. PubMed ID: 2554436 [TBL] [Abstract][Full Text] [Related]
5. Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. Oram JF; Brinton EA; Bierman EL J Clin Invest; 1983 Nov; 72(5):1611-21. PubMed ID: 6313765 [TBL] [Abstract][Full Text] [Related]
6. Effects of monocyte macrophages stimulation on hepatic lipoprotein receptors. Cai HJ; He ZG; Ding YN Biochim Biophys Acta; 1988 Feb; 958(3):334-42. PubMed ID: 2829970 [TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. Vaziri ND; Liang K; Azad H J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260 [TBL] [Abstract][Full Text] [Related]
9. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Innerarity TL; Bersot TP; Arnold KS; Weisgraber KH; Davis PA; Forte TM; Mahley RW Metabolism; 1984 Feb; 33(2):186-95. PubMed ID: 6319954 [TBL] [Abstract][Full Text] [Related]
10. The effects on lipid metabolism of 4-phenyl-5,5-dicarbethoxy-2-pyrrolidenone in Sprague Dawley rats. Hall IH; Wong OT; Reynolds DJ; Chang JJ Acta Pharm Nord; 1992; 4(3):179-86. PubMed ID: 1329835 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of lipoproteins by human fetal hepatocytes. Carr BR Am J Obstet Gynecol; 1987 Dec; 157(6):1338-44. PubMed ID: 2827479 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia. Liang K; Vaziri ND Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409 [TBL] [Abstract][Full Text] [Related]
13. Characterization of high density lipoprotein binding to human adipocyte plasma membranes. Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a human hepatic receptor for high density lipoproteins. Hoeg JM; Demosky SJ; Edge SB; Gregg RE; Osborne JC; Brewer HB Arteriosclerosis; 1985; 5(3):228-37. PubMed ID: 2986587 [TBL] [Abstract][Full Text] [Related]
15. The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat. Roach PD; Kambouris AM; Trimble RP; Topping DL; Nestel PJ FEBS Lett; 1987 Sep; 222(1):159-62. PubMed ID: 2820793 [TBL] [Abstract][Full Text] [Related]
16. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome. Vaziri ND; Liang K Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480 [TBL] [Abstract][Full Text] [Related]
17. Distinction in the mode of receptor-mediated endocytosis between high density lipoprotein and acetylated high density lipoprotein: evidence for high density lipoprotein receptor-mediated cholesterol transfer. Murakami M; Horiuchi S; Takata K; Morino Y J Biochem; 1987 Mar; 101(3):729-41. PubMed ID: 3036788 [TBL] [Abstract][Full Text] [Related]
18. Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity. Havekes LM; de Wit EC; Princen HM Biochem J; 1987 Nov; 247(3):739-46. PubMed ID: 3426559 [TBL] [Abstract][Full Text] [Related]
19. Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley rats. Hall IH; Reynolds DJ; Wong OT; Oswald CB; Murthy AR Pharm Res; 1987 Dec; 4(6):472-9. PubMed ID: 3508559 [TBL] [Abstract][Full Text] [Related]
20. Correlation of low and high density lipoprotein binding in vivo with rates of lipoprotein degradation in the rat. A comparison of lipoproteins of rat and human origin. Koelz HR; Sherrill BC; Turley SD; Dietschy JM J Biol Chem; 1982 Jul; 257(14):8061-72. PubMed ID: 6282871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]